Mayumi Nakagawa

Federal Grant PI High Impact

Professor

University of Arkansas for Medical Sciences

faculty

Pathology, College of Medicine

mnakagawa@uams.edu

29 h-index 143 pubs 2,765 cited

Research Areas

Cancer Immunotherapy and Biomarkers Cervical Cancer and HPV Research Immune Cell Function and Interaction T-cell and B-cell Immunology Microbial infections and disease research Health and Medical Research Impacts Molecular Biology Techniques and Applications

Links

ORCID Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Mayumi Nakagawa's research focuses on understanding and enhancing immune responses, particularly T-cell responses, to high-risk human papillomaviruses (HPVs). She is the Principal Investigator on a renewal grant from the NIH/National Cancer Institute, titled "Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses," which has received $727,264 in funding. Her work investigates the expansion of HPV-specific T cells in both peripheral blood and cervical tissues in individuals receiving therapeutic vaccines, with a focus on cases where high-grade squamous intraepithelial lesions have regressed.

Dr. Nakagawa's recent publications also explore related areas, including the evaluation of DNA extraction protocols from cytology specimens for studying cervical microbiota and the presence of coinfections with other oncoviruses in HPV-positive individuals. She has published 143 scholarly works, accumulating 2,765 citations and an h-index of 29. Her research group includes collaborators such as Sumit Shah, Hannah Coleman, Takeo Shibata, and Yong-Chen Lu, all from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.

Metrics

  • h-index: 29
  • Publications: 143
  • Citations: 2,765

Selected Publications

  • Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025) DOI
  • A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
  • Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus <i>Candida</i> adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024) DOI
  • Coinfections with additional oncoviruses in HPV+ individuals: Status, function and potential clinical implications (2024) DOI
  • A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
  • Assessing the Feasibility of an Online Module for Promoting Cancer Prevention Measures (2021) DOI
  • Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021) DOI
  • Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota (2021) DOI
  • An Online Survey and Focus Groups for Promoting Cancer Prevention Measures (2021) DOI

Federal Grants 1 $727,264 total

NIH/National Cancer Institute Contact PI Jul 2010 - Jun 2026

Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal

National Cancer Institute $727,264 R01

Grants & Funding

  • History of CIN-2 in Adolescents (Subcontract with UCSF 4023sc) NIH/Nat. Cancer Institute - Pass Through: University of California, San Francisco Principal Investigator
  • CD8 T-cell epitopes of high risk human papillomaviruses American Cancer Society, Inc. Principal Investigator
  • Natural History of HPV Infection to Neoplasia (Subcontract with UCSF 4166sc) NIH/Nat. Cancer Institute - Pass Through: University of California, San Francisco Principal Investigator
  • MRNA translational Control of Cell Cycle Progression American Cancer Society, Inc. Principal Investigator
  • Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal NIH/Nat. Cancer Institute Principal Investigator
  • Nakagawa_CPPS Pilot Award UAMS Principal Investigator
  • Natural History of HPV-Infection to Neoplasia NIH/Nat. Cancer Institute - Pass Through: University of California, San Francisco Principal Investigator
  • Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal NIH/Nat. Cancer Institute Principal Investigator

Collaborators

Researchers in the database who share publications

Sumit Shah University of Arkansas for Medical Sciences 5 shared publications Hannah Coleman University of Arkansas for Medical Sciences 5 shared publications Takeo Shibata University of Arkansas for Medical Sciences 5 shared publications Yong‐Chen Lu University of Arkansas for Medical Sciences 4 shared publications Teresa Evans University of Arkansas for Medical Sciences 4 shared publications Michael Scott Robeson University of Arkansas for Medical Sciences 4 shared publications William W. Greenfield University of Arkansas for Medical Sciences 4 shared publications Milan Bimali University of Arkansas for Medical Sciences 4 shared publications

Similar Researchers

Based on overlapping research topics

Thomas A. Williams University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction T-cell and B-cell Immunology
Good match 5 shared topics
Yong‐Chen Lu University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction T-cell and B-cell Immunology
Good match 4 shared topics
Lucy Fry University of Arkansas for Medical Sciences
Immune Cell Function and Interaction Microbial infections and disease research Health and Medical Research Impacts
Good match 4 shared topics
Gopinath Venugopal University of Arkansas for Medical Sciences
Immune Cell Function and Interaction Microbial infections and disease research Health and Medical Research Impacts
Good match 4 shared topics
Hayden Roys University of Arkansas for Medical Sciences
Immune Cell Function and Interaction Microbial infections and disease research Health and Medical Research Impacts
Good match 4 shared topics
Melanie Barker University of Arkansas for Medical Sciences
Immune Cell Function and Interaction T-cell and B-cell Immunology Microbial infections and disease research
Good match 4 shared topics